Discover the detailed record of transactions filed by Debbink Dirk J, Chairman & CEO. Director active across 1 companies, notably Cincinnati Financial CORP. In total, 8 filings have been published. Total volume traded: €353k. The latest transaction was filed on 20 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Dan Yrigoyen is the Chief Executive Officer and Vice President of Sales at Arch Therapeutics, Inc. In this role, he oversees the operations and strategy of the company, focusing on sales growth and innovation. Dan is responsible for strategic direction and customer relationship management, playing a key role in the company's development.